AUSTIN, Texas, Jan. 24, 2025 (GLOBE NEWSWIRE) — Astrotech Corporation (NASDAQ: ASTC) announced the resignation of its Chief Financial Officer, Jaime Hinojosa, effective February 14, 2025. Mr. Hinojosa will continue to serve in the CFO role until February 14, 2025, and after that time will provide transition services to the Company on a consulting basis through June 30, 2025. In connection with this development, the Company and its Board of Directors have appointed Ryan Polk to serve as interim Chief Financial Officer.
“I will be moving to Houston to be closer to family and to work for our family business,” said Mr. Hinojosa. “I am grateful to Tom Pickens, our Chief Executive Officer, and our Board of Directors for allowing me to serve as Astrotech’s CFO. Seeing the growth of our instrument over the last ten years has been exciting and I look forward to seeing the Company’s future developments.”
“Jaime has worked tirelessly to advance our company’s mission,” commented Mr. Pickens. “His leadership of our financial and regulatory reporting and loyal devotion to our employees, customers and suppliers is appreciated. We wish him well and greatly appreciate his contributions. We appreciate Ryan joining our team and accepting the torch from Jaime.”
Mr. Polk will assume the Company’s Chief Financial Officer role effective February 14, 2025 on an interim basis. He has held Chief Financial Officer positions at both public and private entities and brings experience in scaling companies through both organic growth and acquisition.
About Astrotech Corporation
Astrotech (Nasdaq: ASTC) is a mass spectrometry company that launches, manages and commercializes scalable companies based on its innovative core technology through its wholly owned subsidiaries. 1st Detect develops, manufactures, and sells trace detectors for use in the security and detection market. AgLAB develops and sells chemical analyzers for use in the agriculture market. Pro-Control is developing mass spectrometry technology for use in chemical manufacturing processes. BreathTech is developing a breath analysis tool to screen for volatile organic compounds that could indicate infections or critical conditions. Astrotech is headquartered in Austin, Texas. For information, please visit www.astrotechcorp.com.